|
Celera
sanger sequencing data Sanger Sequencing Data, supplied by Celera, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/sanger+sequencing+data/sanger+sequencing+data/pmc06129304__bty189_supplementarynote-47-17-6 Average 90 stars, based on 1 article reviews
sanger sequencing data - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Baylor Genetics
sanger sequencing data Sanger Sequencing Data, supplied by Baylor Genetics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/sanger+sequencing+data/sanger+sequencing+data/pm29957440-77-9-20 Average 90 stars, based on 1 article reviews
sanger sequencing data - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Macrogen
sanger sequence data Sanger Sequence Data, supplied by Macrogen, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/sanger+sequencing+data/sanger+sequence+data/pmc10124277__jitc___2022___005839supp001-3-5-8 Average 90 stars, based on 1 article reviews
sanger sequence data - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Quintara Discovery
sanger sequencing ab1 data Sanger Sequencing Ab1 Data, supplied by Quintara Discovery, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/sanger+sequencing+data/sanger+sequencing+ab1+data/pm31492858-355-0-7 Average 90 stars, based on 1 article reviews
sanger sequencing ab1 data - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
CLC Bio
sanger sequencing data ![]() Sanger Sequencing Data, supplied by CLC Bio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/sanger+sequencing+data/sanger+sequencing+data/pmc05884117-310-2-14 Average 90 stars, based on 1 article reviews
sanger sequencing data - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Glaxo Smith
sanger sequence data ![]() Sanger Sequence Data, supplied by Glaxo Smith, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/sanger+sequencing+data/sanger+sequence+data/pmc03271058-188-0-20 Average 90 stars, based on 1 article reviews
sanger sequence data - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Eurofins
sanger sequencing data ![]() Sanger Sequencing Data, supplied by Eurofins, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/sanger+sequencing+data/sanger+sequencing+data/pmc07549055-158-0-3 Average 90 stars, based on 1 article reviews
sanger sequencing data - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Chakshu Research Inc
sanger sequencing data (electropherogram) ![]() Sanger Sequencing Data (Electropherogram), supplied by Chakshu Research Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/sanger+sequencing+data/sanger+sequencing+data++electropherogram+/pmc11618948__IJN___34___6___678___S1-127-2-19 Average 90 stars, based on 1 article reviews
sanger sequencing data (electropherogram) - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Gene Codes Inc
sanger sequence data analysis ![]() Sanger Sequence Data Analysis, supplied by Gene Codes Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/sanger+sequencing+data/sanger+sequence+data+analysis/pm33550451-74-29-38 Average 90 stars, based on 1 article reviews
sanger sequence data analysis - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
SCHOTT
sanger sequenced data sets ![]() Sanger Sequenced Data Sets, supplied by SCHOTT, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/sanger+sequencing+data/sanger+sequenced+data+sets/pm28957507-66-27-35 Average 90 stars, based on 1 article reviews
sanger sequenced data sets - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
CodonCode corporation
sanger sequence data ![]() Sanger Sequence Data, supplied by CodonCode corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/sanger+sequencing+data/sanger+sequence+data/pmc03125267-89-0-6 Average 90 stars, based on 1 article reviews
sanger sequence data - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Oxford Nanopore
sanger sequencing data of the sec14 locus ![]() Sanger Sequencing Data Of The Sec14 Locus, supplied by Oxford Nanopore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/sanger+sequencing+data/sanger+sequencing+data+of+the+sec14+locus/pm37296137-499-24-7 Average 90 stars, based on 1 article reviews
sanger sequencing data of the sec14 locus - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
Image Search Results
Journal: European journal of immunology
Article Title: Transcription Factor YY1 Can Control AID-mediated Mutagenesis
doi: 10.1002/eji.201747065
Figure Lengend Snippet: YY1 effect on AID-mediated mutations within the Sμ region in IgκAID yy1f/f mice. (A) Average mutation frequency at the Sμ region from 6 independent IgκAID yy1f/f mice. Isolated splenic B cells were either mock treated, or treated with TAT-CRE to delete the yy1 gene, then induced with LPS plus IL4 in culture for 4 days. DNA was isolated, the Sμ region was amplified by PCR, cloned, and subjected to Sanger sequencing. Error bars indicate the standard deviation from the mean. The three asterisks denote p<0.002 in a two tailed T-test. (B) The frequency of Sμ mutation numbers in a sequence (indicated by the numbers around the periphery of the circle) are shown by the size of the pie slice. The total number of sequenced clones is shown in the middle of each pie. (C) Average mutation frequency at the Taci gene from 6 individual mice detected by Sanger sequencing of mock and TAT-CRE treated samples. The same DNA from 6 independent mice used in (A) above was amplified with primers to the Taci gene promoter and individual clones were sequenced. Error bars represent the standard deviation from the mean. There was no statistical difference at the Taci gene between Mock and TAT-CRE treated samples (ns) in a two tailed T-test.
Article Snippet: Analysis of
Techniques: Mutagenesis, Isolation, Amplification, Clone Assay, Sequencing, Standard Deviation, Two Tailed Test
Journal: European journal of immunology
Article Title: Transcription Factor YY1 Can Control AID-mediated Mutagenesis
doi: 10.1002/eji.201747065
Figure Lengend Snippet: YY1 effect on AID mediated mutations and AID genomic localization in ex vivo stimulated splenic B cells from yy1f/f mice. (A) Frequencies of single nucleotide variants (SNVs) in Sμ, Jh4, and Cd83 promoter regions detected by NGS. Splenic B cells isolated from six individual yy1f/f mice were either mock treated or treated with TAT-CRE to delete the yy1 gene. After induction for 4 days with LPS plus IL4, DNA was isolated and DNA sequences at the Sμ, Jh4, and CD83 promoter were subjected to NGS DNA sequencing. The frequencies of single nucleotide varients are shown in mock treated (black columns) or TAT-CRE treated (white columns) mice. Differences between mock and TAT-CRE were calculated using the Wilcoxon test. (B and C) Recruitment of AID to the Sμ region, and YY1 to the Eμ enhancer and rpL30 promoter. Mock and TAT-CRE treated splenic yy1f/f B cells were transduced with retroviral vector pMX-HA-AID, and two days later cells were subjected to ChIP with control anti-IgG or anti-HA antibody (B), or YY1 antibody (C). QPCR was performed with primers that amplify the IgH Sμ region (B) or Eμ enhancer and rpL30 promoter (C). Error bars indicate standard deviation from the mean, and asterisks indicate p<0.001 in a two tailed T-test. (D) Quantitative RT-PCR of IgM germline transcripts in mock and TAT-CRE treated samples. RNA isolated from Mock and TAT-CRE treated samples was evaluated by quantitative RT-PCR with primers that detect the germline IgM transcript. Data are from six independent experiments and error bars show the standard deviation of the mean.
Article Snippet: Analysis of
Techniques: Ex Vivo, Isolation, Next-Generation Sequencing, Sequencing, Transduction, Retroviral, Plasmid Preparation, Control, Standard Deviation, Two Tailed Test, Quantitative RT-PCR
Journal: European journal of immunology
Article Title: Transcription Factor YY1 Can Control AID-mediated Mutagenesis
doi: 10.1002/eji.201747065
Figure Lengend Snippet: Percent Mutations in AID Hotspots. Percent mutations and transitions in G/C nucleotides.
Article Snippet: Analysis of
Techniques: Sequencing
Journal: European journal of immunology
Article Title: Transcription Factor YY1 Can Control AID-mediated Mutagenesis
doi: 10.1002/eji.201747065
Figure Lengend Snippet: Effects of YY1 on AID nuclear export. HEK293T cells were transfected with plasmids expressing either CMV-FlagAID or CMV-FlagAIDΔNES (which deletes the AID nuclear export sequence causing loss of AID nuclear export), along with 6 or 18μg of pCDNA3 vector expressing YY1 (CMV-YY1). Cells were harvested 2 days later and 20 or 40μg of nuclear extract protein was probed on western blots with anti-Flag, anti-YY1, or anti-TFIIB. Representative results from three independent experiments are shown.
Article Snippet: Analysis of
Techniques: Transfection, Expressing, Sequencing, Plasmid Preparation, Western Blot
Journal: Molecular Therapy. Methods & Clinical Development
Article Title: CRISPR-Mediated Base Conversion Allows Discriminatory Depletion of Endogenous T Cell Receptors for Enhanced Synthetic Immunity
doi: 10.1016/j.omtm.2020.09.002
Figure Lengend Snippet: Terminal-CRISPR Lentiviral Vector Configuration Coupling HBV rTCR and CRISPR TRBC1/2 sgRNA Delivery Lentiviral plasmid configuration, coupling the expression of a recombinant T cell receptor (rTCR) against the hepatitis B virus (HBV) envelope surface antigen 183-91 (S183-91) and a T cell receptor beta constant (TRBC)-specific single guide RNA (sgRNA). The S183-91 rTCR is placed under the transcriptional control of an internal human phosphoglycerate kinase 1 (hPGK) promoter, while TRBC1/2 sgRNA is expressed via a human U6 promoter. The rTCR is expressed as a single transcript with the rTCR α chain first, followed by the rTCR β chain separated by a porcine teschovirus-1 2A (P2A) self-cleavage sequence. These recombinant chains are composed of the T cell receptor α variable 34 (TRAV34) and the T cell receptor β variable 28 (TRBV28) domains, as well as either murine TRAC (muTRAC) or murine TRBC 1 (muTRBC1). The rTCR chains contained an additional cysteine-cysteine disulfide bond between murine constant regions. CMV, cytomegalovirus; cPPT, central polypurine tract; WPRE, woodchuck post-transcriptional regulatory element; LTR, long terminal repeat; ΔU3, deleted unique 3′; R, repeat; U5, unique 5′; ψ, psi; D, diversity region; J, joining region.
Article Snippet:
Techniques: CRISPR, Plasmid Preparation, Expressing, Recombinant, Virus, Control, Sequencing
Journal: Molecular Therapy. Methods & Clinical Development
Article Title: CRISPR-Mediated Base Conversion Allows Discriminatory Depletion of Endogenous T Cell Receptors for Enhanced Synthetic Immunity
doi: 10.1016/j.omtm.2020.09.002
Figure Lengend Snippet: Molecular Analysis of On-/Off-Target DNA Editing and Fidelity of CDR3α and β Regions within rTCR mRNA Transcripts (A) Sanger sequencing of on-target editing at TRBC 1/2 loci in eTCR−/rTCR+ cells. (i) Representative EditR analysis with wild-type sequence (top) and four possible bases (side) shown at each position. Target G > A conversions (red box) generate a premature stop codon (Trp > ∗). (ii) Summary of EditR data for three donors at cytosine positions 5 and 6 distal to the PAM, presented as C > T changes (black), non-C > T changes (gray), and no editing (white). Error bars represent ±1 SEM. (iii) NGS analysis of on-target editing of TRBC 1/2 loci and quantification and characterization of indels after BE3 editing found only low levels of small (<10 bp, black) or large (10–100 bp, gray) indels, with the majority of reads presenting with no indels (white). Error bars represent ± 1 SEM. (B) Boxplots showing off-target editing detected by NGS analysis at the top 6 in silico predicted off-target sites for the TRBC 1/2 sgRNA, with comparison of unedited eTCR+/rTCR− and edited eTCR−/rTCR+ groups (n = 3). Larger dots represent outliers; in all cases, ⩽1.3% conversion. Two-tailed independent t test between unmodified (eTCR+/rTCR−) and edited (eTCR−/rTCR+) samples shown for donor 1 (p > 0.5), donor 2 (p = 0.001), and donor 3 (p > 0.1). (C) Serial examination of RNA from rTCR HBs183-91 for 8 days post-coBE3 mRNA delivery (days 5–12 post-activation) found no evidence of promiscuous deamination, with fidelity of CDR3α and CDR3β regions maintained. Amplicon positions are marked above for C residues, and schematic highlights hypervariable CDR3α and CDR3β regions that confer HLA-peptide specificity. CDR3 regions were mapped as a heatmap in R using the gplots library for C > T conversion rates at the marked sites (TCR Clone software: TCRmodel).
Article Snippet:
Techniques: Sequencing, In Silico, Comparison, Two Tailed Test, Activation Assay, Amplification, Software